We first analysed SERTAD4 in CRC and normal intestinal epithelial tissues in the TCGA database, and the findings indicated that SERTAD4 expression was notably greater in normal tissues compared to CRC tissues (Figure 2B, p < 0.05). Here, SERTAD4 is linked to colorectal carcinoma.